Adapalene
A topical retinoid with strong acne evidence and smaller off-label evidence for photoaging.
StrongWhat the evidence says
Adapalene is a topical retinoid developed for acne. Systematic and network reviews support it as an effective treatment for inflammatory and noninflammatory lesions, often used alone or with benzoyl peroxide depending on acne severity.[1][2]
The Strong rating applies to acne. FDA labeling for 0.3% gel covers acne in people aged 12 years and older, with a thin film applied to the affected area rather than spot treatment. Dryness, redness, scaling, and burning are most common in the first month.[3]
Photoaging use is off-label and less certain. A 24-week randomized comparison found 0.3% adapalene noninferior to 0.05% tretinoin for several clinical photoaging measures, and a newer placebo-controlled trial of 0.1% cream reported improvements in wrinkles and pigmentation but also frequent stinging and xerosis.[4][5]
Adapalene is not a quick cosmetic resurfacer: acne can appear worse early, benefits take weeks, and irritation increases when combined too aggressively with peels, scrubs, waxing, or other retinoids. Sun protection remains important, and pregnancy or pregnancy planning should be discussed with a clinician despite low topical absorption.[3][1]
Potential benefits
Side effects and cautions
Evidence breakdown
Randomized trials and systematic reviews firmly support adapalene for acne; photoaging evidence is promising but much thinner and should be interpreted separately.
Acne trials measure lesion counts and global improvement; photoaging trials measure wrinkles and pigmentation.
Acne evidence includes large randomized programs and systematic comparisons.
Local retinoid reactions are well characterized in trials and prescribing information.
Full source list
- Efficacy and safety of topical treatments for acne vulgaris: a systematic review of randomized controlled trials
British Journal of Dermatology · 2024
- Comparative efficacy of pharmacological treatments for acne vulgaris: a network meta-analysis
Journal of the American Academy of Dermatology · 2021
- DIFFERIN (adapalene) gel prescribing information
U.S. Food and Drug Administration · 2023
- Comparable efficacy of adapalene 0.3% gel and tretinoin 0.05% cream as treatment for cutaneous photoaging
European Journal of Dermatology · 2018
- Efficacy and safety of adapalene 0.1% cream for photoaging: a randomized controlled trial
Dermatologic Therapy · 2025
ANABIOTICASubmit a source